Tecan Cavro® components key to made-to-measure robotics
30 July 2013 | By kdm communications
LCTech GmbH has been using Tecan Cavro® components for many years...
List view / Grid view
News
New data for Abbott’s investigational High Sensitive Troponin test shows it may help doctors predict heart attack risk
30 July 2013 | By Abbott
Abbott announced promising results from a study evaluating its High Sensitive Troponin-I (hsTnI) assay...
Lonza and BioWa sign license agreements with Pfizer, Inc.
BioWa, Inc. and Lonza today announced that they have entered into research agreements with Pfizer Inc. allowing the use of the POTELLIGENT® CHOK1SV Cell Line in the research and development of multiple proprietary antibodies in Pfizer’s pipeline.
Merck reaffirms commitment to state AIDS Drug Assistance Programs (ADAPs) through 2014
29 July 2013 | By Merck
Merck and the ADAP Crisis Task Force (ACTF) announced that the company will extend its commitment to support state AIDS Drug Assistance Programs (ADAPs)...
Pfizer signs new agreement with UNICEF to supply a total of up to 740 million doses of Prevenar 13* for the world’s poorest countries through 2025
29 July 2013 | By Pfizer
Pfizer announces reduced advance market commitment price with a further reduction beginning in 2014...
Abbott features solutions to help labs prepare for the evolving healthcare landscape at the AACC Lab Expo
29 July 2013 | By Abbott
As U.S. healthcare providers navigate a changing healthcare climate, clinical laboratories are playing an increasingly important role in helping them prevent medical errors, lower readmission rates, and improve patient care...
GSK adds to its commitment to GAVI Alliance to help protect millions more children against infectious diseases
29 July 2013 | By GlaxoSmithKline
New extension of Synflorix vaccine supply agreement will help protect an additional 80 million children...
Bristol-Myers Squibb and Samsung BioLogics announce biopharmaceutical manufacturing relationship
29 July 2013 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and Samsung BioLogics announced the companies have entered into a 10-year agreement...
PerfecForm® SkyBlue™ high barrier PVC-FREE blister forming web
29 July 2013 | By Perfecseal
Perfecseal introduces a new, high barrier PVC-FREE blister forming web, PerfecForm® SkyBlue™...
Perfecseal high barrier flow wrap provides excellent performance on high speed equipment
29 July 2013 | By
Perfecseal introduces a new high barrier flow wrap specification, PerfecPharm™ P232...
Daiichi Sankyo to Expand Its Collaborative Drug Discovery Program to Germany, Switzerland, and Austria
29 July 2013 | By Daiichi Sankyo
Daiichi Sankyo announced that it will expand its Take a New challenge for Drug diScovery Global Program...
Novartis receives positive CHMP opinion for Ilaris®
26 July 2013 | By Novartis
Novartis announced that the CHMP of the EMA has adopted a positive opinion for the use of Ilaris® (canakinumab)...
Merck statement regarding CHMP review of incretin-based therapies for type 2 diabetes, including sitagliptin
26 July 2013 | By Merck
“Nothing is more important to us than the safety of our medicines..."
GSK receives positive CHMP opinion for REVOLADETM in thrombocytopenia associated with chronic hepatitis C infection
26 July 2013 | By GlaxoSmithKline
“A sustained virologic response is the goal for treatment of hepatitis C infection..."
Afatinib receives positive CHMP opinion for patients with EGFR mutation positive lung cancer in European Union
26 July 2013 | By Boehringer Ingelheim
"Boehringer Ingelheim welcomes the decision by the CHMP..."
